Pediatric bronchiectasis: No longer an orphan disease

Area of Science:

• Pediatric Pulmonology
• Respiratory Medicine
• Clinical Research

Background:

• Bronchiectasis is a chronic pulmonary disorder with persistent cough and irreversible bronchial dilatation.
• In children, symptoms may differ, with reversible dilatation in early stages.
• Increasingly recognized for significant childhood morbidity and mortality globally.

Purpose of the Study:

• To summarize current knowledge on pediatric bronchiectasis epidemiology, pathobiology, clinical features, and management.
• To highlight recent advances in understanding the disease's heterogeneous nature.
• To identify remaining knowledge gaps and future research directions.

Main Methods:

• Review of current literature on pediatric bronchiectasis.
• Synthesis of epidemiological data.
• Analysis of pathobiological mechanisms and clinical presentations.

Main Results:

• Bronchiectasis results from a complex interplay of host, pathogens, and environment, creating a cycle of infection and inflammation.
• Recent evidence implicates viruses and suggests new therapeutic avenues including novel drugs and vaccines.
• Management strategies are evolving, moving beyond cystic fibrosis paradigms.

Conclusions:

• Significant gaps persist in understanding the initiating and sustaining mechanisms of pediatric bronchiectasis.
• Further progress requires national/international collaboration, standardized endpoints, and novel prevention strategies.
• Addressing these gaps is vital for improving treatment and prevention of this life-limiting disease.